Exparel Injection Effect on Postoperative Opioid Usage
Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Sep 9, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Patients will be identified in clinic as good candidates for surgical intervention based on current standard of care. Once participants are consented, they will be randomly placed into one of three categories. The first category being patients undergoing surgery with local injection of lidocaine and epinephrine as is current practice. The second category of patients will undergo surgery with local injection of bupivacaine HCL and epinephrine preincision. The third group will undergo surgery with local injection of lidocaine and epinephrine preincision and Exparel postincision. As stated abo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 years Patients requiring parathyroid/thyroid surgery based on the standard of care English as primary language
- Exclusion Criteria:
- • Patients under the age of 18 years Patients with previous history of opioid abuse Patients with a true allergy to any local anesthetic Patients with a true allergy to any opioid
About University Of Missouri Columbia
The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Patients applied
Trial Officials
Tabitha Galloway, MD
Principal Investigator
University of Missouri Department of Otolaryngology-Head and Neck Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials